Net profit of Beryl Drugs remain constant at Rs 0.01 crore in the quarter ended September 2025 and also during the previous quarter ended September 2024. Sales declined 8.73% to Rs 5.12 crore in the quarter ended September 2025 as against Rs 5.61 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales5.125.61 -9 OPM %14.269.98 - PBDT0.650.44 48 PBT0.260.11 136 NP0.010.01 0 Powered by Capital Market - Live News

Beryl Drugs will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live News

Beryl Drugs announced that the Annual General Meeting(AGM) of the company will be held on 30 September 2025.Powered by Capital Market - Live News

Beryl Drugs will hold a meeting of the Board of Directors of the Company on 2 September 2025.Powered by Capital Market - Live News

Net profit of Beryl Drugs declined 94.59% to Rs 0.02 crore in the quarter ended June 2025 as against Rs 0.37 crore during the previous quarter ended June 2024. Sales declined 23.36% to Rs 4.79 crore in the quarter ended June 2025 as against Rs 6.25 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales4.796.25 -23 OPM %11.4815.84 - PBDT0.450.78 -42 PBT0.070.50 -86 NP0.020.37 -95 Powered by Capital Market - Live News